Not Signed In -
Evening Primrose |
Fever Plant; Oenothera biennis; Oenothera species; OEP; Sun Drop |
Clinical Trial: Trial Comparing Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening as Add-on to Oral Antidiabetic Drug(s) in Subjects with Type 2 Diabetes
This study is currently recruiting patients.
|
Purpose
This trial will compare the use of insulin determir once a day to NPH insulin once a day when added to treatment with oral antidiabetic agents in patients with Type 2 diabetes. HbA1C results on each treatment will be measured and compared.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Diabetes Mellitus, Type II | Drug: insulin detemir Drug: NPH (insulin) | Phase III |
MedlinePlus related topics: Diabetes
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study
Further Study Details:
Primary Outcomes: HbA1C results
Expected Total Enrollment: 500
Expected Total Enrollment: 500
Study start: February 2005; Expected completion: December 2005
Last follow-up: October 2005; Data entry closure: November 2005
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
- Type II diabetics age 18 or older that have had diabetes for at least 12 months.
Location and Contact Information
Novo Nordisk Clinical Trial Call Center 866-867-7178
Alabama
Calera, Alabama, 35040, United States; Recruiting
Arizona
Phoenix, Arizona, 85029, United States; Recruiting
Mesa, Arizona, 85205, United States; Recruiting
California
Anaheim, California, 92801, United States; Recruiting
Fullerton, California, 92835, United States; Recruiting
San Diego, California, 92128, United States; Recruiting
La Jolla, California, 92037, United States; Recruiting
Colorado
Wheat Ridge, Colorado, 80033, United States; Recruiting
Massachusetts
Waltham, Massachusetts, 02453, United States; Recruiting
Fall River, Massachusetts, 02721, United States; Recruiting
Missouri
Jefferson City, Missouri, 65109, United States; Recruiting
Nevada
N. Las Vegas, Nevada, 89030, United States; Recruiting
New York
New York, New York, 10029, United States; Recruiting
Lewiston, New York, 14092, United States; Recruiting
Williamsville, New York, 14221, United States; Recruiting
North Dakota
Grand Forks, North Dakota, 58201, United States; Recruiting
Ohio
Cincinnati, Ohio, 45291, United States; Recruiting
Dayton, Ohio, 45406, United States; Recruiting
Pennsylvania
Reading, Pennsylvania, 19606, United States; Recruiting
Connellsville, Pennsylvania, 15425, United States; Recruiting
Norristown, Pennsylvania, 19401, United States; Recruiting
South Carolina
Greer, South Carolina, 29651, United States; Recruiting
Texas
Conroe, Texas, 77384, United States; Recruiting
Harker Heights, Texas, 75648, United States; Recruiting
Washington
Seattle, Washington, 98195, United States; Recruiting
More Information
Study ID Numbers: NN304-1632
Record last reviewed: April 2005
Last Updated: April 6, 2005
Record first received: February 23, 2005
ClinicalTrials.gov Identifier: NCT00104182
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: April 2005
Last Updated: April 6, 2005
Record first received: February 23, 2005
ClinicalTrials.gov Identifier: NCT00104182
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
